About INBX Dividend Returns
Inhibrx Biosciences, Inc. (INBX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of INBX over the past year?
Inhibrx Biosciences, Inc. (INBX) delivered a return of 459.47% over the past year. Since INBX does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in INBX be worth today?
A $10,000 investment in Inhibrx Biosciences, Inc. one year ago would be worth $55,947 today, representing a gain of $45,947.
Q3Does INBX pay dividends?
Inhibrx Biosciences, Inc. (INBX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For INBX, the total return equals the price-only return.
Q4Did INBX beat the S&P 500?
Yes, Inhibrx Biosciences, Inc. (INBX) outperformed the S&P 500 by 444.02 percentage points over the past year. INBX delivered a total return of 459.47%, compared to the S&P 500's 15.45%. This 444.02pp alpha means investors in INBX earned more than a passive S&P 500 index fund.
Q5What is INBX's worst drawdown?
Inhibrx Biosciences, Inc. (INBX) experienced a maximum drawdown of -26.36% over the past year, declining from its peak on 2025-03-24 to its trough on 2025-05-14. The stock recovered to its prior peak by 2025-06-10. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is INBX's long-term total return over 10, 20, or 30 years?
Inhibrx Biosciences, Inc. (INBX) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 263.5% (13.8% CAGR) — $10,000 would have grown to $36,345. Over 20 years: 263.5% total return (6.7% CAGR) — $10,000 → $36,345. Over 30 years: 263.5% total return (4.4% CAGR) — $10,000 → $36,345. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was INBX's best and worst year?
Inhibrx Biosciences, Inc.'s best calendar year was 2025 with a total return of 418.0%. Its worst year was 2024 with a total return of -57.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 475.3 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).